Complement-mediated Thrombosis
Complement-Mediated Thrombosis is a pathophysiological mechanism of thrombosis characterized by the aberrant activation of the complement system, which directly promotes coagulation cascade initiation, endothelial cell activation, and platelet aggregation, distinguishing it from thrombotic processes driven primarily by hemodynamic, platelet-intrinsic, or coagulation-factor-dominant pathways.
236
Publications
19.8K
Citations
1.4K
Authors
477
Institutions
Publications per year
2017–2026
91
Parents
236
Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic–Uremic Syndrome
Christophe Legendre, Christoph Licht, Petra Muus et al. · New England Journal of Medicine · 2013 · 1.6K citations · Full text
1–5 of 236
1.4K
Mario Negri Institute for Pharmacological Research, Italy
10 publications · 2.8K citations
10
h-index
10
h-index
9
h-index
Mario Negri Institute for Pharmacological Research, Italy
8 publications · 1.2K citations
8
h-index
5
h-index
1–5 of 1.4K
477
University of Pennsylvania
Philadelphia, United States
11 h-index
27 publications
3.5K citations
Nordland Hospital
Bodø, Norway
10 h-index
21 publications
659 citations
Oslo University Hospital
Oslo, Norway
10 h-index
26 publications
1.2K citations

University of Oslo
Oslo, Norway
9 h-index
19 publications
698 citations

Mario Negri Institute for Pharmacological Research
Milan, Italy
9 h-index
59 publications
6.5K citations
UiT The Arctic University of Norway
Tromsø, Norway
8 h-index
42 publications
1K citations
University of Bern
Bern, Switzerland
7 h-index
21 publications
832 citations
The Ohio State University
Columbus, United States
6 h-index
19 publications
818 citations
1–8 of 477
20 publications · 3.9K citations
17
h-index
Repository · 10 publications · 500 citations
10
h-index
JI · 10 publications · 1.1K citations
10
h-index
8 publications · 524 citations
8
h-index
7 publications · 203 citations
7
h-index
1–5